Hyperfine, Inc. (HYPR): Gross Profit
$6.75M
Year ended 2025-12-31
$8.50M
Trailing 12 months to 2026-06-30
+95.3%
3-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.75M | +14.6% | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | $5.89M | +23.8% | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | $4.76M | +424.5% | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | $907.0K | n/m | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | -$1.17M | n/m | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | -$477.0K | n/a | 2022-03-25, From 2020-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $6.75M | +14.6% |
| CapsoVision, Inc (CV) | 2025-12-31 | $7.17M | +12.5% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $5.51M | +7.1% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $8.58M | +225.2% |
| Precision Optics Corporation, Inc. (POCI) | 2025-06-30 | $3.40M | -41.3% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $5.12M | -9.7% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $27.79M | +29.9% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $17.07M | +17.0% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $3.01M | +29.4% |
Compare HYPR, CV, ESMC, QTI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗